Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S2215-0366(19)30045-8

Publication URI: http://dx.doi.org/10.1016/S2215-0366(19)30045-8

Type: Journal Article/Review

Parent Publication: The Lancet Psychiatry

Issue: 4